Press Releases

GelStat Corporation's Wholly Owned Subsidiary Mastix Medica Launches a New Website

Download PDF

HUNT VALLEY, MD -- (Marketwired) -- 12/07/15 -- GelStat Corporation (OTC PINK: GSAC), which develops and manufactures niche healthcare products such as tableted chewing gum, chewable tablets and lozenges announced today that its wholly owned subsidiary, Mastix Medica, has launched a new website at www.MastixMedica.com

The new website is the first step in a multi-faceted business-to-business marketing plan to drive revenue growth and highlights the Company's unique manufacturing capabilities.

Bob Estey, founder of Mastix Medica and GelStat's CEO, said, "I am thrilled to have completed the first step in our new marketing plan and look forward to adding more content, videos and features over the next few months. This is an important part of the plan as we need to inform potential customers and consumers about the many benefits of using chewing gum and/or dissolvable lozenges as a delivery method for their products." A few of the key benefits include:

  • Can improve compliance as studies show 40% of people have difficulty swallowing pills
  • Faster acting than ingested tablets, capsules and liquids
  • Can improve the amount of active delivered since it bypasses the first-pass metabolism
  • Convenient and discreet since no liquid required for swallowing pills
  • Widely acceptable and very familiar to consumers

Mr. Estey further said, "In addition to these benefits, our proprietary, patent-pending manufacturing process provides customers with significant barriers-to-entry from competitors. Why? Because our proprietary manufacturing process makes it extremely difficult for competitors to offer similar products. This solves a major challenge facing companies looking for alternative product formats to launch new dietary supplement or food products."

To access the Company's current investment presentations go to: http://ir.stockpr.com/gelstat2/presentations

Make sure you are first to receive timely information on GelStat Corporation when it hits the newswire. Sign up for GelStat's email news alert system today at: http://ir.stockpr.com/gelstat2/email-alerts

ABOUT GELSTAT CORPORATION

GelStat Corporation is a holding company and through its wholly owned subsidiary, Mastix Medica, develops, manufactures and markets niche healthcare products such as tableted chewing gum, chewable tablets and lozenges. Mastix is one of very few companies in the world (and the only one in the U.S.) that has the ability to make tableted chewing gum products at room temperature versus the traditional high heat process which degrades the active ingredients and reduces their efficacy. Most importantly, Mastix is the only company that manufactures its own powdered gum base using its proprietary process. This allows Mastix the flexibility to create custom formulations that other companies cannot and do not offer. Furthermore, it has a patent pending process for its unique gum manufacturing process that also includes incorporating hemp oil (CBD) into chewing gum, lozenges and chewable tablets. The Company manufactures its products in a 28,000 square foot facility just north of Baltimore in Hunt Valley, Maryland. The products are manufactured in a Kosher certified (Star-K), allergen-free and quality-driven FDA GMP-compliant manufacturing environment.

For more information, visit www.gelstat.com or www.mastixmedica.com

CBD (Cannabidiol) is a natural constituent of hemp oil, which is a well-known dietary supplement and food ingredient. Naturally occurring CBD in hemp oil processed from industrial hemp possesses no psychoactive qualities. Gelstat, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA).

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE: These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

Safe Harbor Statement

This press release contains forward-looking statements including the projected revenue that Mastix may produce, the forecasted size of the migraine market and the forecasted value of the energy drink market. Forward-looking statements can be identified by words such as "anticipates," "intends," "plans," "seeks," "believes," "estimates," "expects" and similar references to future periods.

Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you therefore against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements include the ability of Mastix to obtain future customers, regulatory and other legal changes which may affect the forecasts, and the demand for hemp based products as well as the ability to sell hemp products.

Any forward-looking statement made by us in this press release speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

FOR ADDITIONAL INFORMATION CONTACT:
Gerald Kieft
CFO
GelStat Corporation
410-316-1082

Source: GelStat Corporation